Showing results (381-390 of 450) with videos related to
Sort By:
Pageof 45
Cell & Bioscience|February 1, 2025
Classifications of triple-negative breast cancer: insights and current therapeutic approachesZiqi Chen, Yumeng Liu, Minchuan Lyu, et al.The Journal of Pathology|April 14, 2016
Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profilesZheming Lu, Jindong Sheng, Yujie Zhang, et al.Journal of Proteome Research|July 4, 2013
Serum metabolic signatures of four types of human arthritisMiao Jiang, Tianlu Chen, Hui Feng, et al.Frontiers in Pharmacology|July 30, 2019
Identification of Characteristic Autoantibodies Associated With Deficiency Pattern in Traditional Chinese Medicine of Rheumatoid Arthritis Using Protein ChipsHeru Zhao, Yin Zhang, Bin Liu, et al.Scientific Reports|February 26, 2016
New strategy for drug discovery by large-scale association analysis of molecular networks of different speciesBo Zhang, Yingxue Fu, Chao Huang, et al.Frontiers in Pharmacology|March 14, 2022
An Integrative Pharmacology Model for Decoding the Underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid ArthritisJie Wu, Kexin Wang, Qinwen Liu, et al.Bioinformatics (Oxford, England)|February 11, 2015
Large-scale exploration and analysis of drug combinationsPeng Li, Chao Huang, Yingxue Fu, et al.Frontiers in Pharmacology|October 25, 2023
Corrigendum: An integrative pharmacology model for decoding the underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid arthritisJie Wu, Kexin Wang, Qinwen Liu, et al.Journal of Agricultural and Food Chemistry|May 1, 2019
Destiny of Dendrobium officinale Polysaccharide after Oral Administration: Indigestible and Nonabsorbing, Ends in Modulating Gut MicrobiotaLifeng Li, Hong Yao, Xiaojun Li, et al.Cancer Letters|July 5, 2024
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapyYuan Ma, Huarui Zhang, Xinyang Shen, et al.Pageof 45